Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, Alabama.
Alabama College of Osteopathic Medicine, Dothan, Alabama.
Sports Health. 2020 Jan/Feb;12(1):94-98. doi: 10.1177/1941738119880256. Epub 2019 Oct 30.
Mixed results exist regarding the benefit of orthobiologic injections. The purpose of this study was to assess the variability in costs for platelet-rich plasma (PRP) and stem cell (SC) injections and evaluate for variables that influence pricing.
There will be significant variability in the cost of PRP and SC injections throughout the United States.
Descriptive epidemiology study.
Level 3.
Calls were made to 1345 orthopaedic sports medicine practices across the United States inquiring into the availability of PRP or SC knee injections and associated costs. In addition to pricing, the practice type, number of providers, and population and income demographics were recorded. Univariate statistical analyses were used to identify differences in availability and cost between variables.
Of the contacted offices that provided information on both PRP and SC availability (n = 1325), 268 (20.2%) offered both treatments, 550 (41.5%) offered only PRP injections, 20 (1.5%) offered only SC injections, and 487 (36.8%) did not offer either treatment. The mean ± SD cost of a PRP injection was $707 ± $388 (range, $175-$4973), and the mean cost of an SC injection was $2728 ± $1584 (range, $300-$12,000). Practices offering PRP and SC injections tended to be larger (PRP, 12.0 physicians per practice vs. 8.1 [ < 0.001]; SC, 13.6 vs 9.7 [ < 0.001]). Practices that offered PRP injections were located in areas with higher median household income ( = 0.047). Variables associated with higher cost of PRP injections included city population ( < 0.001) and median income of residents ( < 0.001).
While the majority of sports medicine practices across the United States offer some type of orthobiologic injection, there exists significant variability in the cost of these injections.
This study demonstrates the significant variability in costs of orthobiologic injections throughout the country, which will allow sports medicine physicians to appreciate the value of these injections when counseling patients on available treatment options.
关于骨生物学注射的益处,结果喜忧参半。本研究旨在评估富血小板血浆(PRP)和干细胞(SC)注射的成本差异,并评估影响定价的变量。
全美范围内 PRP 和 SC 注射的成本存在显著差异。
描述性流行病学研究。
3 级。
向全美 1345 家骨科运动医学诊所致电,询问 PRP 或 SC 膝关节注射的可用性及其相关费用。除了价格外,还记录了诊所类型、提供者人数以及人口和收入情况。使用单变量统计分析来确定变量之间可用性和成本的差异。
在所联系的提供 PRP 和 SC 可用性信息的办公室中(n = 1325),268 个(20.2%)提供了两种治疗方法,550 个(41.5%)仅提供 PRP 注射,20 个(1.5%)仅提供 SC 注射,487 个(36.8%)未提供任何一种治疗。PRP 注射的平均±SD 费用为 707 ± 388 美元(范围为 175-4973 美元),SC 注射的平均费用为 2728 ± 1584 美元(范围为 300-12000 美元)。提供 PRP 和 SC 注射的诊所往往规模较大(PRP:每个诊所 12.0 名医生 vs. 8.1 [ < 0.001];SC:13.6 名 vs. 9.7 [ < 0.001])。提供 PRP 注射的诊所位于中位数家庭收入较高的地区(= 0.047)。与 PRP 注射较高费用相关的变量包括城市人口(<0.001)和居民中位数收入(<0.001)。
尽管全美大多数运动医学诊所都提供某种类型的骨生物学注射,但这些注射的费用存在显著差异。
本研究表明,全国范围内骨生物学注射的成本存在显著差异,这将使运动医学医生在为患者提供可用治疗方案的咨询时了解这些注射的价值。